Compression stockings versus compression plus antibiotics to prevent repeat skin infections
Part of Infections, Skin clinical trials.
This study compares two ways to prevent repeated erysipelas (a bacterial skin infection) in the lower legs. It tests whether wearing compression therapy alone is as effective as a combination of compression plus an antibiotic pill.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have had at least 2 episodes of erysipelas (a skin infection) in the same leg within the last year, but no more than 5 episodes in total.
- Your most recent episode must have been diagnosed within the last 3 months.
- You must not be severely obese (body mass index under 40).
- You must be able to put on compression stockings or bandages yourself or with help.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a stronger compression method for people with long-lasting leg swelling (edema) that is not caused by another medical condition. The goal is to see if it works better than standard care.
This trial tests whether a short course of amoxicillin (an antibiotic) is as effective as the standard, longer course for treating erysipelas, a bacterial skin infection that causes redness, swelling, and pain in the lower legs. If you qualify, you would take the antibiotic for either 6 or 12 days, which may mean fewer side effects and a quicker return to your normal routine.
This study tests a wound treatment using topical antibiotics or antiseptics to help chronic (long-lasting) leg ulcers heal and control local infection. It may help people whose ulcers are not responding well to standard care.
This study tests whether a daily pill called apremilast can reduce the number of new blisters in people with a genetic form of EBS (epidermolysis bullosa simplex). If you get more than 3 new blisters per day and have a confirmed KRT5 or KRT14 mutation, this trial may be a good fit.
This study tests whether cleaning the skin to remove a common bacteria (Staph aureus) can help reduce eczema symptoms. It may offer a new way to manage eczema without relying only on creams or injections.
This trial tests if a new version of a special dressing (Suprasorb X+PHMB Pro) works better than the current version for treating infected venous leg ulcers. It may help people with mildly to moderately draining wounds that are infected.
Hear when a new Recurrent Erysipelas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.